DLTR
66
4
CMI
42
3
MTCH
44
4
BBY
43
-5
LEG
39
6
CLX
43
4
EOG
50
-5
CRM
32
5
MDT
64
4
PM
75
-2
EMN
50
2
JPM
57
5
PH
67
3
URI
50
-2
EQR
44
13
STT
64
5
NWL
41
10
DGX
61
4
R
65
2
PCAR
39
5
DLTR
66
4
CMI
42
3
MTCH
44
4
BBY
43
-5
LEG
39
6
CLX
43
4
EOG
50
-5
CRM
32
5
MDT
64
4
PM
75
-2
EMN
50
2
JPM
57
5
PH
67
3
URI
50
-2
EQR
44
13
STT
64
5
NWL
41
10
DGX
61
4
R
65
2
PCAR
39
5
Financhill
Back

Berkshire Hathaway Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
32

BRK.A
Berkshire Hathaway

Last Price:
$725,910.01
Seasonality Move:
3.62%
Sell
36

APLS
Apellis Pharmaceuticals

Last Price:
$17.77
Seasonality Move:
-0.62%
Sell
32
Berkshire Hathaway (BRK.A) is a Sell

Is Berkshire Hathaway a Buy, Sell or Hold?

  • The current Berkshire Hathaway [BRK.A] share price is $735,920.00. The Score for BRK.A is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BRK.A is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $18.30. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRK.A Stock Price Chart

What is Berkshire Hathaway's stock price today?

  • The Berkshire Hathaway share price today is $735,920.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.A is experiencing slight buying pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $18.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BRK.A Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9847.55 Sell
Relative Strength Index (14 RSI): 39.4 Sell
Chaikin Money Flow: 156 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (751064.82 - 751088.82) Sell
Bollinger Bands (100): (755390.98 - 755450.98) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.14 Buy
Relative Strength Index (14 RSI): 47.43 Sell
Chaikin Money Flow: -398519 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.09 - 19.05) Buy
Bollinger Bands (100): (17.95 - 27.07) Sell

BRK.A Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 735441.71 Buy
20-day SMA: 747742.28 Sell
50-day SMA: 765081.26 Sell
200-day SMA: 723029.33 Buy
8-day EMA: 737043.62 Sell
20-day EMA: 746384.26 Sell
50-day EMA: 756311.77 Sell
200-day EMA: 722042.2 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.13 Sell
20-day SMA: 18.32 Sell
50-day SMA: 18.37 Sell
200-day SMA: 27.16 Sell
8-day EMA: 18.84 Sell
20-day EMA: 18.58 Sell
50-day EMA: 19.42 Sell
200-day EMA: 27.25 Sell

Berkshire Hathaway Earnings Growth & BRK.A Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1,917.50 per share, a decrease next quarter of $1,787.00 per share, an increase this year of $1,115.14 per share, and an increase next year of $1,599.50 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

Berkshire Hathaway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):